» Articles » PMID: 22378505

Artesunate Induces Apoptosis Via a Bak-mediated Caspase-independent Intrinsic Pathway in Human Lung Adenocarcinoma Cells

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2012 Mar 2
PMID 22378505
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

This report is designed to explore the exact molecular mechanism by which artesunate (ART), a semisynthetic derivative of the herbal antimalaria drug artemisinin, induces apoptosis in human lung adenocarcinoma (ASTC-a-1 and A549) cell lines. ART treatment induced ROS-mediated apoptosis in a concentration- and time-dependent fashion accompanying the loss of mitochondrial potential and subsequent release of Smac and AIF indicative of intrinsic apoptosis pathway. Blockage of casapse-8 and -9 did not show any inhibitory effect on the ART-induced apoptosis, but which was remarkably prevented by silencing AIF. Of the utmost importance, ART treatment induced the activation of Bak but not Bax, and silencing Bak but not Bax remarkably inhibited ART-induced apoptosis and AIF release. Furthermore, although ART treatment did not induced a significant down-regulation of voltage-dependent anion channel 2 (VDAC2) expression and up-regulation of Bim expression, silencing VDAC2 potently enhanced the ART-induced Bak activation and apoptosis which were significantly prevented by silencing Bim. Collectively, our data firstly demonstrate that ART induces Bak-mediated caspase-independent intrinsic apoptosis in which Bim and VDAC2 as well as AIF play important roles in both ASTC-a-1 and A549 cell lines, indicating a potential therapeutic effect of ART for lung cancer.

Citing Articles

Natural products targeting ferroptosis pathways in cancer therapy (Review).

Na X, Li L, Liu D, He J, Zhang L, Zhou Y Oncol Rep. 2024; 52(3).

PMID: 39054952 PMC: 11292301. DOI: 10.3892/or.2024.8782.


Artesunate Exerts Organ- and Tissue-Protective Effects by Regulating Oxidative Stress, Inflammation, Autophagy, Apoptosis, and Fibrosis: A Review of Evidence and Mechanisms.

Zhu M, Wang Y, Han J, Sun Y, Wang S, Yang B Antioxidants (Basel). 2024; 13(6).

PMID: 38929125 PMC: 11200509. DOI: 10.3390/antiox13060686.


Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates.

Marchesi E, Perrone D, Navacchia M Pharmaceutics. 2023; 15(9).

PMID: 37765156 PMC: 10536797. DOI: 10.3390/pharmaceutics15092185.


Efficacy of artesunate in asthma: based on network pharmacology and molecular docking.

Zhang J, Lin J J Thorac Dis. 2023; 15(4):1658-1674.

PMID: 37197555 PMC: 10183554. DOI: 10.21037/jtd-22-1437.


Degradation kinetics of artesunate for the development of an ex-tempore intravenous injection.

Gashe F, Wynendaele E, De Spiegeleer B, Suleman S Malar J. 2022; 21(1):256.

PMID: 36068561 PMC: 9450271. DOI: 10.1186/s12936-022-04278-4.